A detailed view on pacemaker lead parameters remotely transmitted after magnetic resonance

Pacing and Clinical Electrophysiology : PACE
Christian G WollmannHarald Mayr

Abstract

The purpose of this study was to analyze potential influences of magnetic resonance (MR) on the course of automatically device-based assessed lead parameters remotely transmitted in patients who were implanted with MR-conditional permanent pacemakers (PMs) and who had nondiagnostic brain and lumbar spine MR (1.5T) within the ProMRI single center pilot study. The ProMRI study evaluated the feasibility of the Evia PMs with Safio S leads (Biotronik SE&Co KG, Berlin, Germany) in the MR environment. All patients were equipped with remote monitoring on the day of MR. Atrial (RA) und ventricular (RV) lead parameters (sensing, pacing capture threshold [PCT], pacing impedance) were automatically assessed and remotely transmitted on a daily or event-triggered basis for 3 months post MR. Remotely transmitted data were normalized for potential differences between at-daytime (in-office) and at-night-time (remotely) assessed parameters using the 1-month follow-up data for each patient. Confidence intervals of continuous data were calculated day-wise with one sample t-tests of post-MR/pre-MR differences, respectively. A total of 2,428 data sets (mean 80 ± 20 per patient) were transmitted. Mean values for the different lead parameters were (RA...Continue Reading

References

Dec 25, 2004·European Heart Journal·Roger LuechingerPeter Boesiger
May 5, 2005·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·A SchmiedelT Sommer
Jan 31, 2006·American Heart Journal·Frank G ShellockDaniel S Berman
Mar 1, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ariel RoguinTorsten Sommer
Mar 5, 2008·Biomedical Engineering Online·Eugenio MatteiPietro Bartolini
Sep 30, 2008·Journal of Magnetic Resonance Imaging : JMRI·Giovanni CalcagniniHoward I Bassen
Jan 6, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Saman Nazarian, Henry R Halperin
Sep 2, 2010·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Peter NordbeckWolfgang R Bauer
Oct 12, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bruce L WilkoffUNKNOWN EnRhythm MRI SureScan Pacing System Study Investigators
Oct 14, 2011·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Werner JungSebastian Jäckle
Oct 29, 2011·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Jerold S ShinbaneFrank G Shellock
Dec 1, 2011·European Heart Journal·Philippe MaboUNKNOWN COMPAS Trial Investigators
Sep 27, 2012·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Christian G WollmannHarald Mayr
Jan 22, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·J Rod GimbelUNKNOWN Advisa MRI System Study Investigators
Jun 3, 2014·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Christian G WollmannSebastian Globits
Jun 7, 2014·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Olaf M MuehlingAlexander Becker
Dec 3, 2014·Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes·Atul VermaSantanu Chakraborty

❮ Previous
Next ❯

Citations

Dec 8, 2020·Pacing and Clinical Electrophysiology : PACE·Saurabh DeshpandeDeepak Padmanabhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved